CareDx
CDNA
159 hedge funds and large institutions have $903M invested in CareDx in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 50 increasing their positions, 60 reducing their positions, and 40 closing their positions.
231% more call options, than puts
Call options by funds: $5.41M | Put options by funds: $1.63M
2.61% more ownership
Funds ownership: 96.1% → 98.7% (+2.6%)
2% less capital invested
Capital invested by funds: $921M → $903M (-$17.3M)
9% less funds holding
Funds holding: 174 → 159 (-15)
17% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 60
25% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 40
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
Top Sellers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$21.4M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$12.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.23M |
| 4 |
Two Sigma Advisers
New York
|
-$7.53M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.22M |
CDNA Hedge Fund Activity: Q4 2019 in Review
159 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q4 2019, worth a combined $903M — down 1.9% from $921M a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of CDNA and 30 opened new positions — a net loss of 10 holders — while 60 trimmed existing stakes and 50 added.
The largest buyer was Consonance Capital Management, adding an estimated $32M. The largest seller was Lord, Abbett & Co, cutting an estimated $21.4M.
- 159 institutional investors held CareDx (CDNA) as of Q4 2019, down from 174 in Q3 2019.
- Funds reported $903M of CareDx stock for Q4 2019, down 1.9% quarter-over-quarter.
- 30 funds opened new CareDx positions in Q4 2019 and 40 closed out, a net change of -10 holders.
- The largest CareDx buyer in Q4 2019 was Consonance Capital Management, an estimated $32M added.
- The largest CareDx seller in Q4 2019 was Lord, Abbett & Co, an estimated $21.4M sold.
Based on aggregated 13F filings for Q4 2019.